1 |
Bost, F., McKay, R., Bost, M., Potapova, O., Dean, N. M., et al. (1999) The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol. Cell. Biol. 19, 1938.1949
|
2 |
Brumby, A. M. and Richardson, H. E. (2003) scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. EMBO J. 22, 5769.5779
DOI
ScienceOn
|
3 |
Butterfield, L., Zentrich, E., Beekman, A., and Heasley, L. E. (1999) Stress and cell type-dependent regulation of transfected cJun N-terminal kinase and mitogen-activated protein kinase kinase isoforms. Biochem. J. 338, 681−686
DOI
ScienceOn
|
4 |
Engelberg, D. (2004) Stress-activated protein kinases-tumor suppressors or tumor initiators- Semin Cancer Biol. 14, 271-282
DOI
ScienceOn
|
5 |
Farooq, A. and Zhou, M. M. (2004) Structure and regulation of MAPK phosphatases. Cell Signal. 16, 769-779
DOI
ScienceOn
|
6 |
Gonzalez-Garcia, A., Pritchard, C. A., Paterson, H. F., Mavria, G., Stamp, G., et al. (2005) RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7, 219-226
DOI
ScienceOn
|
7 |
Hideshima, T., Hayashi, T., Chauhan, D., Akiyama, M., Richardson, P., et al. (2003) Biologic sequelae of c-Jun NH(2)-terminal kinase (JNK) activation in multiple myeloma cell lines. Oncogene 22, 8797-8801
DOI
ScienceOn
|
8 |
Hoornaert, I., Marynen, P., Goris, J., Sciot, R., and Baens, M. (2003) MAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p12-13, reduces BCR-ABL-induced transformation. Oncogene 22, 7728-7736
DOI
|
9 |
Kennedy, N. J., Sluss, H. K., Jones, S. N., Bar-Sagi, D., Flavell, R. A., et al. (2003) Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dev. 17, 629-637
DOI
ScienceOn
|
10 |
Kim, H. L., Vander Griend, D. J., Yang, X., Benson, D. A., Dubauskas, Z., et al. (2001) Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res. 61, 2833-2837
|
11 |
Rennefahrt, U. E., Illert, B., Kerkhoff, E., Troppmair, J., and Rapp, U. R. (2002) Constitutive JNK activation in NIH 3T3 fibroblasts induces a partially transformed phenotype. J. Biol. Chem. 277, 29510-29518
DOI
ScienceOn
|
12 |
Sabapathy, K., Jochumm W., Hochedlinger, K., Chang, L., Karin, M., et al. (1999) Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Dev. 89, 115-124
DOI
|
13 |
Vicent, S., Garayoa, M., Lopez-Picazo, J. M., Lozano, M. D., Toledo, G., et al. (2004) Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Clin. Cancer Res. 10, 3639-3649
DOI
ScienceOn
|
14 |
Winn, R. A., Marek, L., Han, S. Y., Rodriguez, K., Rodriguez, N., et al. (2005) Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation. J. Biol. Chem. 280, 19625-19634
DOI
ScienceOn
|
15 |
Xia, Y. and Karin, M. (2004) The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol. 14, 94-101.
DOI
ScienceOn
|
16 |
Yang, Y. M., Bost, F., Charbono, W., Dean, N., McKay, R., et al. (2003) C-Jun NH2-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. Clin. Cancer Res. 9, 391-401
|
17 |
Yoshida, S., Fukino, K., Harada, H., Nagai, H., Imoto, I., et al. (2001) The c-Jun NH2-terminal kinase3 (JNK3) gene: genomic structure, chromosomal assignment, and loss of expression in brain tumors. J. Hum. Genet. 46, 182-187
DOI
ScienceOn
|
18 |
Vasilevskaya, I. and O'Dwyer, P. J. (2003) Role of Jun and Jun kinase in resistance of cancer cells to therapy. Drug Resist. Updat. 6, 147-156
DOI
ScienceOn
|
19 |
Theodosiou, A. and Ashworth, A. (2002) MAP kinase phosphatases. Genome Biol. 3, REVIEWS3009
|
20 |
Park, H. S., Kim, M. S., Huh, S. H., Park, J., Chung, J., et al. (2002) Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J. Biol. Chem. 277, 2573-2578
DOI
ScienceOn
|
21 |
Han, S. Y., Kim, S. H., and Heasley, L. E. (2002) Differential gene regulation by specific gain-of-function JNK1 proteins expressed in Swiss 3T3 fibroblasts. J. Biol. Chem. 277, 47167-47174
|
22 |
Murtagh, J., McArdle, E., Gilligan, E., Thornton, L., Furlong, F., et al. (2004) Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling. J. Cell. Biol. 166, 133-143
DOI
ScienceOn
|
23 |
Yamanaka, H., Moriguchi, T., Masuyama, N., Kusakabe, M., Hanafusa, H., et al. (2002) JNK functions in the noncanonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep. 3, 69-75
DOI
ScienceOn
|
24 |
Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanaugh, J., Sluss, H. K., et al. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760-2770
|
25 |
Kuan, C. Y., Yang, D. D., Samanta Roy, D. R., Davis, R. J., Rakic, P., et al. (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667-676
DOI
ScienceOn
|
26 |
Fuchs, S. Y., Fried, V. A., and Ronai, Z. (1998b) Stress-activated kinases regulate protein stability. Oncogene 17, 1483-1490
DOI
|
27 |
Masuda, K., Shima, H., Katagiri, C., and Kikuchi, K. (2003) Activation of ERK induces phosphorylation of MAPK phosphatase- 7, a JNK specific phosphatase, at Ser-446. J. Biol. Chem. 278, 32448-32456
DOI
ScienceOn
|
28 |
Maesako, Y., Uchiyama, T., and Ohno, H. (2003) Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma. Cancer Sci. 94, 774-781
DOI
ScienceOn
|
29 |
Xu, Y. (2003) Regulation of p53 responses by post-translational modifications. Cell Death Differ. 10, 400-403
DOI
ScienceOn
|
30 |
Toh, W. H., Siddique, M. M., Boominathan, L., Lin, K. W., and Sabapathy, K. (2004) c-Jun regulates the stability and activity of the p53 homologue, p73. J. Biol. Chem. 279, 44713-44722
DOI
ScienceOn
|
31 |
Yang, D., Kuan, C.-Y., Whitmarsh, A. J., Rincon, M., Zheng, T. S., et al. (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the JNK3 gene. Nature 389, 865-870
DOI
ScienceOn
|
32 |
MacCorkle, R. A. and Tan, T. H. (2004) Inhibition of JNK2 disrupts anaphase and produces aneuploidy in mammalian cells. J. Biol. Chem. 279, 40112-40121
DOI
ScienceOn
|
33 |
Milne, D. M., Campbell, L. E., Campbell, D. G., and Meek, D. W. (1995) p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1. J. Biol. Chem. 270, 5511-5518
DOI
ScienceOn
|
34 |
Buschmann, T., Potapova, O., Bar-Shira, A., Ivanov, V. N., Fuchs, S. Y., et al. (2001) Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol. 21, 2743−2754
DOI
ScienceOn
|
35 |
Yamada, S. D., Hickson, J. A., Hrobowski, Y., Vander Griend, D. J., Benson, D., et al. (2002) Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res. 62, 6717-6723
|
36 |
Mingo-Sion, A. M., Marietta, P. M., Koller, E., Wolf, D. M., and Van Den Berg, C. L. (2004) Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene 23, 596-604
DOI
ScienceOn
|
37 |
Fuchs, S. Y., Adler, V., Pincus, M. R., and Ronai, Z. (1998a) MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA 95, 10541-10546
|
38 |
McEwen, D. G. and Peifer, M. (2005) Puckered, a Drosophila MAPK phosphatase, ensures cell viability by antagonizing JNK-induced apoptosis. Development 132, 3935-3946
DOI
ScienceOn
|
39 |
Weston, C. R., Wong, A., Hall, J. P., Goad, M. E., Flavell, R. A., et al. (2004) The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis. Proc. Natl. Acad. Sci. USA 101, 14114-14119
|
40 |
She, Q. B., Chen, N., Bode, A. M., Flavell, R. A., and Dong, Z. (2002) Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol- 13-acetate. Cancer Res. 62, 1343-1348
|
41 |
Martin, P. and Parkhurst, S. M. (2004) Parallels between tissue repair and embryo morphogenesis. Development 131, 3021-3034
DOI
ScienceOn
|
42 |
Noselli, S. and Agnes, F. (1999) Roles of the JNK signaling pathway in Drosophila morphogenesis. Curr. Opin. Genet. Dev. 9, 466-472
DOI
ScienceOn
|
43 |
Uhlirova, M., Jasper, H., and Bohmann, D. (2005) Non-cellautonomous induction of tissue overgrowth by JNK/Ras cooperation in a Drosophila tumor model. Proc. Natl. Acad. Sci. USA 102, 13123-13128
|
44 |
Wang, H. Y., Cheng, Z., and Malbon, C. C. (2003) Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. Cancer Lett. 191, 229-237
DOI
ScienceOn
|
45 |
Srinivas, H., Juroske, D. M., Kalyankrishna, S., Cody, D. D., Price, R. E., et al. (2005) c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha. Mol. Cell. Biol. 25, 1054-1069
DOI
ScienceOn
|
46 |
Wallingford, J. B., Fraser, S. E., and Harland, R. M. (2002) Convergent extension: the molecular control of polarized cell movement during embryonic development. Dev. Cell. 2, 695-706
DOI
ScienceOn
|
47 |
Behrens, A., Jochum, W., Sibilia, M., and Wagner, E. F. (2000) Oncogenic transformation by ras and fos is mediated by c- Jun N-terminal phosphorylation. Oncogene 19, 2657.2663
DOI
ScienceOn
|
48 |
Eferl, R. and Wagner, E. F. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868
DOI
ScienceOn
|
49 |
Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., and Karin, M. (1991) Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354, 494-496
DOI
ScienceOn
|
50 |
Okubo, Y., Blakesley, V. A., Stannard, B., Gutkind, S., and Le Roith, D. (1998) Insulin-like growth factor-1 inhibits the stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem. 273, 25961-25966
DOI
|
51 |
Johnson, G. L. and Lapadat, R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912
DOI
ScienceOn
|
52 |
Kyriakis, J. M. and Avruch, J. (2001) Mammalian mitogenactivated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869
DOI
|
53 |
Mialon, A., Sankinen, M., Soderstrom, H., Junttila, T. T., Holmstrom, T., et al. (2005) DNA topoisomerase I is a cofactor for c-Jun in the regulation of epidermal growth factor receptor expression and cancer cell proliferation. Mol. Cell. Biol. 25, 5040-5051
DOI
ScienceOn
|
54 |
Nelson, W. J. and Nusse, R. (2004) Convergence of Wnt, betacatenin, and cadherin pathways. Science 303, 1483-1487
DOI
ScienceOn
|
55 |
Smeal, T., Binetruy, B., Mercola, D., Grover-Bardwick, A., Heidecker, G., et al. (1992) Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol. Cell. Biol. 12, 3507-3513
DOI
|
56 |
Yamagata, H., Matsuzaki, K., Mori, S., Yoshida, K., Tahashi, Y., et al. (2005) Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis. Cancer Res. 65, 157-165
|
57 |
Gioeli, D., Black, B. E., Gordon, V., Spencer, A., Kesler, C. T., et al. (2006) Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol. Endocrinol. 20, 503-515
DOI
ScienceOn
|
58 |
Cerezo, A., Martinez-A, C., Lanzarot, D., Fischer, S., Franke, T. F., et al. (1998) Role of Akt and c-Jun N-terminal kinase 2 in apoptosis induced by interleukin-4 deprivation. Mol. Biol. Cell 8, 3107−3118
|
59 |
Chen, N., Nomura, M., She, Q. B., Ma, W. Y., Bode, A. M., et al. (2001) Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res. 61, 3908-3912
|
60 |
Hess, P., Pihan, G., Sawyers, C. L., Flavell, R. A., and Davis, R. J. (2002) Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat. Genet. 32, 201-205
DOI
ScienceOn
|
61 |
Levresse, V., Butterfield, L., Zentrich, E., and Heasley, L. E. (2000) Akt negatively regulates the cJun N-terminal kinase pathway in PC12 cells. J. Neurosci. Res. 62, 799-808
DOI
ScienceOn
|
62 |
Lowe, S. W., Cepero, E., and Evan, G. (2004) Intrinsic tumour suppression. Nature 432, 307-315
DOI
ScienceOn
|
63 |
Manning, A. M. and Davis, R. J. (2003) Targeting JNK for therapeutic benefit: from junk to gold- Nat. Rev. Drug Discov. 2, 554-565
DOI
ScienceOn
|
64 |
Derijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., et al. (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037
DOI
ScienceOn
|
65 |
Nateri, A. S., Spencer-Dene, B., and Behrens, A. (2005) Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 437, 281-285
DOI
ScienceOn
|
66 |
Vander Griend, D. J., Kocherginsky, M., Hickson, J. A., Stadler, W. M., Lin, A., et al. (2005) Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res. 65, 10984-10991
DOI
ScienceOn
|
67 |
Brumby, A. M. and Richardson, H. E. (2005) Using Drosophila melanogaster to map human cancer pathways. Nat. Rev. Cancer 5, 626−639
DOI
ScienceOn
|
68 |
Yoshida, B. A., Dubauskas, Z., Chekmareva, M. A., Christiano, T. R., Stadler, W. M., et al. (1999) Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res. 59, 5483-5487
|
69 |
Veeman, M. T., Axelrod, J. D., and Moon, R. T. (2003) A second canon. Functions and mechanisms of beta-cateninindependent Wnt signaling. Dev. Cell 5, 367-377
DOI
ScienceOn
|
70 |
Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J. P., et al. (2003) Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112, 181-192
DOI
ScienceOn
|